More than a million square feet of lab space are under construction to house the region’s leading life sciences companies and biotech entrepreneurs.
Several vaccines for the novel coronavirus could be ready by mid-December. Here’s what — and how long — it’ll take to make them accessible to those who need them.
Of the 900 COVID-19 clinical trials launched around the world, very few have been related to pregnancy — even though pregnant women are more likely to have worse outcomes from the virus than non-pregnant women.
NeuroRX has a history of pursuing treatments for illnesses abandoned by others. Their latest drug had been shelved for 20 years until they unearthed it this March.
Drew Weissman, a professor of infectious diseases at the University of Pennsylvania whose technology the promising vaccine is based on, explains how it works.
Tia Lyles-Williams, CEO of LucasPye Bio, is carving a path to bring more affordable drugs to market — and to make her industry more inclusive.
Here’s a look at how far Philly companies have gotten in the development process — and how far there is yet to go.
If you’re going through cancer treatment, it’s important you don’t do it alone. In Philly, you don’t have to.
Cancer screenings are down this year, which is an issue that should concern us all.
Take a look at the medical marvels being pioneered right here.
With the season of family gatherings upon us, here are five ways to make your holiday celebrations safer for all.
A local health policy expert breaks down what each presidential candidate plans to do with the existing health-care law and how it might affect Philadelphians.
MBF Therapeutics is applying its expertise in developing gene-based vaccines for use in pets to discover a vaccine that’ll provide longer-lasting immunity to the coronavirus.
Experts weigh in on the often misconstrued form of resistance to the spread of infectious disease and explain why it might not be the best way to bring the COVID-19 pandemic to an end.